Hemosol Inc. preclinical data

HML (Toronto) presented preclinical findings with its hemoglobin product at the conference on Current Issues in Blood Substitute Research and Development in San Diego, showing that kidney function in an isolated kidney perfusion model improved with Hemolink, compared to washed red cells.

In an animal model of trauma, fluid resuscitation with Hemolink was more successful in improving circulation, compared to whole blood or electrolyte solutions. ...